Human Induced Pluripotent Stem Cell-Derived Exosomes as a New Therapeutic Strategy for Various Diseases

Int J Mol Sci. 2021 Feb 10;22(4):1769. doi: 10.3390/ijms22041769.

Abstract

Recently, an increasing number of studies have demonstrated that induced pluripotent stem cells (iPSCs) and iPSC-derived cells display therapeutic effects, mainly via the paracrine mechanism in addition to their transdifferentiation ability. Exosomes have emerged as an important paracrine factor for iPSCs to repair injured cells through the delivery of bioactive components. Animal reports of iPSC-derived exosomes on various disease models are increasing, such as in heart, limb, liver, skin, bone, eye and neurological disease and so forth. This review aims to summarize the therapeutic effects of iPSC-derived exosomes on various disease models and their properties, such as angiogenesis, cell proliferation and anti-apoptosis, with the hopes of improving their potential role in clinical applications and functional restoration.

Keywords: cell-free regenerative medicine; exosome; induced pluripotent stem cells.

Publication types

  • Review

MeSH terms

  • Animals
  • Cell Proliferation
  • Exosomes / metabolism
  • Exosomes / transplantation*
  • Humans
  • Induced Pluripotent Stem Cells / cytology*
  • Induced Pluripotent Stem Cells / metabolism
  • Neovascularization, Physiologic
  • Paracrine Communication
  • Regenerative Medicine / methods*